Hanne Callewaert (PhD) is co-founder and CEO of AstriVax. She has 20+ years of experience in the life sciences through a PhD in Medical Sciences, Masters in IP, followed by global industry experience in GSK Vaccines and smaller biotech environment, like Oxurion, Oncurious and AstriVax.  She has a strong background in drug and vaccine development expertise blended with business and corporate development through executive leadership functions as Vaccine Development Leader at GSK, Chief Operating Officer at Oxurion, followed by her current CEO position at AstriVax. She has been involved in development of commercial, late- or early-stage vaccines, monoclonal antibodies, peptides and small molecules. She has built AstriVax from an academic technology platform to a nearly clinical stage company with a coherent and well-experienced team of 25+ people in one year timeframe. She is also the proud mom of 4 kids ranging between 11 and 17 years old and enjoys spending time with the family and friends, traveling and sports.